ca 125 | he 4 | ||
Apr-20 | 1000+ | 化疗:紫杉醇+卡铂 ,3程 | |
2020/6/18 | 手术 | ||
2020/6/19 | 卵巢及大网膜病理:卵巢高级别浆液性癌。免疫组化:ER80%、P16+,PR30%, P53-,WT-1-,Ki67 5%,MSH-2+, MSH-6+,PMS-2+,MLH-1+ | ||
2021/5/7 | 24 | ||
2022/7/10 | 70 | CT发现新发肝肿物 | |
2022/7/9 | 腹膜肿物病理:高级别浆液性癌累及。免疫组化:pax-8+,wt-1+, p53突变,ER20%+, P16+, beta-catenin 膜浆+, PR10%+, Vimentin- | ||
2022/8/1 | <20 | 化疗:紫杉醇+卡铂 | |
2022/8/24 | 化疗:紫杉醇+卡铂 | ||
2022/9/18 | 化疗:紫杉醇+卡铂 | ||
2022/10/6 | 化疗:紫杉醇+卡铂 | ||
2022/10/28 | 化疗:紫杉醇+卡铂 | ||
2022/11/12 | 23 | 化疗:紫杉醇+卡铂 | |
基因检测:BRCA突变+ | |||
口服奥拉帕利 |
欢迎光临 探论癌症临床管理研究所 (http://tanlunforcancer.net/) | X3.4 |